Study Summary
This trial is testing a new diabetes prevention program (NDPP-Flex) to see if it's better than the standard program at improving blood sugar levels, reducing diabetes risk, and helping people lose weight. The study will enroll 200 adults with prediabetes who are normal weight or overweight/obese.
- Prediabetes
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: 12 months
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
National Diabetes Prevention Program
1 of 2
NDPP-Flex
1 of 2
Active Control
Experimental Treatment
200 Total Participants · 2 Treatment Groups
Primary Treatment: NDPP-Flex · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 85 · Female Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is this study currently searching for participants?
"According to clinicaltrials.gov, this trial is no longer accepting new recruits as it was last updated on September 26th 2022, following its initial listing date of December 10th 2022. However there are 198 other available studies searching for volunteers at the present moment." - Anonymous Online Contributor
To which demographic is enrollment in this research endeavor open?
"To join this trial, recruits should have a prediabetic A1C reading of 5.7-6.4%, BMI over 20 kg/m2 (or 18.5 for Asian individuals), be affiliated with Denver Health and possess either English or Spanish language proficiency; the age range is from 18 to 85 years old and 200 participants are currently sought after." - Anonymous Online Contributor
Is it possible for individuals over fifty years of age to participate in this research?
"The minimal age of admittance for this particular trial is 18, while the maximum age allowed to enroll is 85." - Anonymous Online Contributor